Ainos (AIMD) Competitors $3.80 -0.23 (-5.71%) As of 09:02 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock AIMD vs. ARTV, STRO, BYSI, JATT, VTVT, NRXP, VNRX, INKT, DTIL, and RLMDShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include Artiva Biotherapeutics (ARTV), Sutro Biopharma (STRO), BeyondSpring (BYSI), JATT Acquisition (JATT), vTv Therapeutics (VTVT), NRx Pharmaceuticals (NRXP), VolitionRx (VNRX), MiNK Therapeutics (INKT), Precision BioSciences (DTIL), and Relmada Therapeutics (RLMD). These companies are all part of the "pharmaceutical products" industry. Ainos vs. Its Competitors Artiva Biotherapeutics Sutro Biopharma BeyondSpring JATT Acquisition vTv Therapeutics NRx Pharmaceuticals VolitionRx MiNK Therapeutics Precision BioSciences Relmada Therapeutics Artiva Biotherapeutics (NASDAQ:ARTV) and Ainos (NASDAQ:AIMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk. Do analysts recommend ARTV or AIMD? Artiva Biotherapeutics currently has a consensus price target of $18.25, suggesting a potential upside of 215.96%. Given Artiva Biotherapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Artiva Biotherapeutics is more favorable than Ainos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Artiva Biotherapeutics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60Ainos 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Does the media prefer ARTV or AIMD? In the previous week, Artiva Biotherapeutics had 6 more articles in the media than Ainos. MarketBeat recorded 8 mentions for Artiva Biotherapeutics and 2 mentions for Ainos. Ainos' average media sentiment score of 0.76 beat Artiva Biotherapeutics' score of 0.75 indicating that Ainos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artiva Biotherapeutics 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ainos 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings & valuation, ARTV or AIMD? Ainos has lower revenue, but higher earnings than Artiva Biotherapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArtiva Biotherapeutics$250K564.43-$65.37MN/AN/AAinos$20K906.30-$14.86M-$4.99-0.76 Is ARTV or AIMD more profitable? Artiva Biotherapeutics' return on equity of -42.60% beat Ainos' return on equity.Company Net Margins Return on Equity Return on Assets Artiva BiotherapeuticsN/A -42.60% -37.76% Ainos N/A -108.25%-56.94% Which has more volatility and risk, ARTV or AIMD? Artiva Biotherapeutics has a beta of 2.83, indicating that its stock price is 183% more volatile than the S&P 500. Comparatively, Ainos has a beta of 2.25, indicating that its stock price is 125% more volatile than the S&P 500. SummaryArtiva Biotherapeutics beats Ainos on 8 of the 11 factors compared between the two stocks. Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMD vs. The Competition Export to ExcelMetricAinosMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.13M$2.64B$6.08B$10.55BDividend YieldN/A57.78%5.73%4.78%P/E Ratio-0.7622.9184.6627.19Price / Sales906.30774.24608.04132.91Price / CashN/A175.9337.8662.13Price / Book0.695.4112.386.65Net Income-$14.86M$33.06M$3.32B$276.79M7 Day Performance0.80%0.18%2.25%1.75%1 Month Performance10.79%10.61%9.63%5.15%1 Year Performance38.84%-3.10%73.84%36.96% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDAinos1.4422 of 5 stars$3.80-5.7%N/A+53.3%$18.13M$20K-0.7640Analyst ForecastARTVArtiva Biotherapeutics3.8529 of 5 stars$3.01+3.8%$17.00+464.8%-79.6%$73.53M$250K0.0081News CoverageSTROSutro Biopharma4.1883 of 5 stars$0.87+2.9%$4.47+415.2%-76.6%$73.50M$62.04M-0.34240News CoveragePositive NewsGap UpBYSIBeyondSpringN/A$1.79-0.6%N/A-25.3%$71.99M$1.75M0.0080JATTJATT AcquisitionN/A$4.17+6.1%N/A-10.8%$71.93MN/A0.003High Trading VolumeVTVTvTv Therapeutics1.5308 of 5 stars$22.47-0.4%$35.50+58.0%+49.2%$71.66M$1.02M-7.209Analyst ForecastGap DownNRXPNRx Pharmaceuticals3.0174 of 5 stars$3.55-3.4%$34.50+873.2%+147.2%$70.23MN/A-1.582Analyst ForecastVNRXVolitionRx2.5998 of 5 stars$0.65-0.6%$3.50+441.8%-39.1%$69.51M$1.32M-1.7980News CoverageGap UpINKTMiNK Therapeutics2.324 of 5 stars$14.96+0.4%$37.50+150.7%+109.3%$67.62MN/A-5.1930DTILPrecision BioSciences3.908 of 5 stars$5.65-0.5%$47.00+731.7%-26.3%$67.32M$68.70M-0.65200RLMDRelmada Therapeutics2.5183 of 5 stars$2.02+1.3%$1.00-50.4%-42.6%$66.88MN/A-0.9110 Related Companies and Tools Related Companies ARTV Competitors STRO Competitors BYSI Competitors JATT Competitors VTVT Competitors NRXP Competitors VNRX Competitors INKT Competitors DTIL Competitors RLMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIMD) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
